Carregant...
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
BACKGROUND: Zoledronic acid is a potent inhibitor of osteoclast-mediated bone resorption and has been widely used in bone metastasis malignancies and postmenopausal osteoporosis as a preventive therapy against skeletal-related events. The purpose of this study was to evaluate the clinical outcome of...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874690/ https://ncbi.nlm.nih.gov/pubmed/24283946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-80 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|